SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-077684
Filing Date
2008-04-09
Accepted
2008-04-09 08:01:12
Documents
3
Period of Report
2008-04-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 12249
2 PRESS RELEASE dex991.htm EX-99.1 12402
3 GRAPHIC g76066image001.jpg GRAPHIC 5198
  Complete submission text file 0001193125-08-077684.txt   33493
Mailing Address 222 THIRD AVENUE SUITE 2300 CAMBRIDGE MA 02142
Business Address 222 THIRD AVENUE SUITE 2300 CAMBRIDGE MA 02142 (617) 557-9020
Targanta Therapeutics Corp. (Filer) CIK: 0001398161 (see all company filings)

IRS No.: 203971077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33730 | Film No.: 08746575
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1